Table 1 Characteristics of patients with malignant melanoma brain metastases.
From: Melanoma GPA as a novel prognostic scoring model based on initial brain metastasis velocity
Characteristics | n (111) | % | |
|---|---|---|---|
Age (year) | Mean (SD) | 57.8 (10.7) | – |
Sex | Male | 55 | 49.5 |
Female | 56 | 50.5 | |
Date of BM (year) | Mean (SD) | 1.9 (2.5) | − |
Number of BM | Mean (SD) | 3.6 (4.5) | − |
iBMV | Median (IQR) | 2.27 (0.86–8.44) | − |
≤ 2.27 | 55 | 49.5 | |
>2.27 | 56 | 50.5 | |
Primary site | Skin | 23 | 20.7 |
Limb | 54 | 48.6 | |
Mucosa | 22 | 19.8 | |
Conjunctiva | 2 | 1.8 | |
Unknown | 10 | 9.0 | |
KPS | ≥ 80 | 94 | 84.7 |
<80 | 17 | 15.3 | |
LDH | ≤ULN | 58 | 52.3 |
> ULN | 53 | 47.7 | |
Alb | ≤ 40 | 56 | 50.5 |
>40 | 55 | 49.5 | |
Meningeal metastasis | Yes | 22 | 19.8 |
No | 89 | 80.2 | |
Maximum diameter of BM (cm) | Mean (SD) | 1.9 (1.4) | – |
Cerebral hemorrhage | Yes | 21 | 18.9 |
No | 90 | 81.1 | |
BM with a midline shift | Yes | 15 | 13.5 |
No | 96 | 86.5 | |
Extracranial metastasis | Yes | 94 | 84.7 |
No | 17 | 15.3 | |
Clinical syndromes | Yes | 67 | 60.4 |
No | 44 | 39.6 |
